Minerva Neurosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Minerva Neurosciences Inc: Is Infosys Ltd. worth buying?
Item: Minerva Neurosciences Inc
Rating: 1.24175
Author: Trendlyne DVM scores

about

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candid...

5.50 -0.05 (-0.90%)

55.86% Fall from 52W High

63,000

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

49.7 / 100

No estimates available

Minerva Neurosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Minerva Neurosciences Inc Live Stock Price Today, Share Analysis and Chart

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candid...

55.86% Fall from 52W High

SWOT Analysis

Minerva Neurosciences Inc Live Price Chart